Welby Inc.

Research Welby Inc. (4438.T) on Bullrun: market cap JPY 2.46B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is JPY 2.46B.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025JPY 635.72M-JPY 539.69M-JPY 430.72M70.6%-65.21JPY 711.43MJPY 605.71MJPY 272.33M
FY2024JPY 528.04M-JPY 804.60M-JPY 776.25M71.9%-98.61JPY 740.43MJPY 200.00MJPY 810.02M
FY2023JPY 575.50M-JPY 505.29M-JPY 258.71M65.4%-64.51JPY 883.36MJPY 1.21MJPY 1.09B
FY2022JPY 1.05BJPY 33.91M-JPY 146.86M71.9%4.33JPY 830.82MJPY 8.35MJPY 1.27B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18JPY 2.46Bn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 JPY.

About Welby Inc.

Welby Inc. engages in the provision of digital health solutions that help patients to get medical care services in Japan. The company provides services in the areas of diabetes, lifestyle-related disease, autoimmune disease, rare disease, oncology, and blood disorders. It also engages in the medical data research business; and operates apps, web services, and data management. Welby Inc. was incorporated in 2011 and is headquartered in Chuo, Japan.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Welby Inc.'s market cap?

Welby Inc.'s market capitalization is JPY 2.46B.

What does Welby Inc. do?

Welby Inc. engages in the provision of digital health solutions that help patients to get medical care services in Japan. The company provides services in the areas of diabetes, lifestyle-related disease, autoimmune disease, rare disease, oncology, and blood disorders. It also engages in the medical data research business; and operates apps, web services, and data management. Welby Inc. was incorporated in 2011 and is headquartered in Chuo, Japan.